Tag: Diabetes: Type II
Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation
This finding is seen despite evidence of better short-term glycemic control in this population
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
GLP-1 RAs linked to lower risk among those with type 2 diabetes and without diabetes; greater protection seen versus metformin, insulin
AI-Enabled Bundle of Sensors, Coaching Aids Type 2 Diabetes Outcomes
Significant improvements seen in glycemic control, weight loss, and de-escalation of glucose-lowering pharmacotherapy versus usual care
MedDiet Plus Energy Reduction, Physical Activity Cuts Incidence of Type 2 Diabetes
Energy-reduced MedDiet plus physical activity and behavioral strategies for weight loss beneficial for individuals with overweight or obesity and metabolic syndrome
DASH Diet Modified for Diabetes Lowers Blood Glucose Levels
The DASH for Diabetes -- DASH4D -- diet is similar to the original DASH diet but lower in carbohydrates and higher in unsaturated fats
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
A number of young adults eligible for GLP-1 RAs are uninsured
Higher Intake of Total Potatoes Linked to Type 2 Diabetes Risk
Replacing three weekly servings of potatoes with whole grains estimated to lower T2D rates
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
Higher proportion of participants achieved HbA1c levels below 6.5 percent with canagliflozin versus placebo
Three Healthy Dietary Patterns Lower Incidence of Type 2 Diabetes Across Ethnicities
No significant heterogeneity seen across ethnic groups, nor evidence of small-study bias
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
